Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

COVID-19: FDA Warns Of Potential Risks Of Antibody Tests

Apr 22 2020

• By Elizabeth Orr

Coronavirus

Related Content

Ready, Set, Go: ‘Unprecedented’ FDA Guidance Aims To Unburden Coronavirus Test Makers, Speed Process

Mar 17 2020

COVID-19: FDA Anticipates Further Serology Test Development

Apr 17 2020

Related Companies

Mount Sinai Health System

Chembio Diagnostic Systems, Inc.

Additional Topics

United States Regulation Coronavirus COVID-19 Enforcement FDA Research & Development Review Pathway Medical Device In Vitro Diagnostics

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window